Publicaciones en las que colabora con Jesús Egido de los Ríos (135)

2024

  1. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy

    Kidney International, Vol. 105, Núm. 6, pp. 1279-1290

  2. Prognostic and therapeutic monitoring value of plasma and urinary cytokine profile in primary membranous nephropathy: the STARMEN trial cohort

    Clinical Kidney Journal, Vol. 17, Núm. 8

2022

  1. The Synthetic Flavonoid Hidrosmin Improves Endothelial Dysfunction and Atherosclerotic Lesions in Diabetic Mice

    Antioxidants, Vol. 11, Núm. 12

2021

  1. Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy

    Kidney International, Vol. 99, Núm. 5, pp. 1179-1188

  2. Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy

    Journal of the American Society of Nephrology, Vol. 32, Núm. 2

  3. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

    Kidney International, Vol. 99, Núm. 4, pp. 986-998

2020

  1. Cardiovascular damage in COVID-19: Therapeutic approaches targeting the renin-angiotensin-aldosterone system

    International Journal of Molecular Sciences, Vol. 21, Núm. 18, pp. 1-18

  2. Galectin-3 is associated with cardiovascular events in post-acute coronary syndrome patients with type-2 diabetes

    Journal of Clinical Medicine, Vol. 9, Núm. 4

2019

  1. Nrf2 plays a protective role against intravascular hemolysis-mediated acute kidney injury

    Frontiers in Pharmacology, Vol. 10

  2. Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases

    Cardiovascular diabetology, Vol. 18, Núm. 1, pp. 140

2017

  1. Diagnostic approaches for diabetic cardiomyopathy

    Cardiovascular Diabetology, Vol. 16, Núm. 1

  2. Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes

    Cardiovascular Diabetology, Vol. 16, Núm. 1

2015

  1. A european multicentre and open-label controlled randomized trial to evaluate the efficacy of sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: The STARMEN study

    Clinical Kidney Journal, Vol. 8, Núm. 5, pp. 503-510

  2. Vitamina D, receptor de la vitamina D e importancia de su activación en el paciente con enfermedad renal crónica

    Nefrologia, Vol. 35, Núm. 1, pp. 28-41

2014

  1. IL-17A is a novel player in dialysis-induced peritoneal damage

    Kidney International, Vol. 86, Núm. 2, pp. 303-315

2013

  1. Bisphenol a in chronic kidney disease

    International Journal of Nephrology, Vol. 2013

  2. Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients

    Transplantation

  3. Eplerenone enhances cardioprotective effects of standard heart failure therapy through matricellular proteins in hypertensive heart failure

    Journal of Hypertension, Vol. 31, Núm. 11, pp. 2309-2319

  4. Gremlin is a downstream profibrotic mediator of transforming growth factor-beta in cultured renal cells

    Nephron - Experimental Nephrology, Vol. 122, Núm. 1-2, pp. 62-74

  5. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 33, Núm. 3, pp. 612-620